Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cd180 | Rat | 17beta-estradiol | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of CD180 mRNA | CTD | PMID:19693291 | Cd180 | Rat | 17beta-estradiol | multiple interactions | ISO | CD180 (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in decreased expression of CD180 mRNA | CTD | PMID:22217510 | Cd180 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cd180 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CD180 mRNA | CTD | PMID:26377647 | Cd180 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Cd180 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of CD180 mRNA | CTD | PMID:38648751 | Cd180 | Rat | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of CD180 mRNA | CTD | PMID:30723492 | Cd180 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Cd180 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of CD180 mRNA | CTD | PMID:39298647 | Cd180 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of CD180 mRNA | CTD | PMID:31881176 | Cd180 | Rat | aflatoxin B1 | increases methylation | ISO | CD180 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of CD180 gene | CTD | PMID:27153756 | Cd180 | Rat | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of CD180 mRNA | CTD | PMID:35163327 | Cd180 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of CD180 mRNA | CTD | PMID:30779732 | Cd180 | Rat | antirheumatic drug | decreases expression | ISO | CD180 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of CD180 mRNA | CTD | PMID:24449571 | Cd180 | Rat | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of CD180 mRNA | CTD | PMID:36841081 | Cd180 | Rat | Azoxymethane | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD180 more ... | CTD | PMID:29950665 | Cd180 | Rat | benzo[a]pyrene | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CD180 mRNA] | CTD | PMID:22228805 | Cd180 | Rat | benzo[a]pyrene | affects methylation | ISO | CD180 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CD180 3' UTR | CTD | PMID:27901495 | Cd180 | Rat | benzo[a]pyrene | increases methylation | ISO | CD180 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of CD180 promoter | CTD | PMID:27901495 | Cd180 | Rat | benzo[a]pyrene | increases expression | ISO | Cd180 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CD180 mRNA | CTD | PMID:22228805 | Cd180 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Cd180 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of CD180 mRNA | CTD | PMID:28085963 | Cd180 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CD180 mRNA | CTD | PMID:25181051|PMID:34947998 | Cd180 | Rat | bisphenol A | increases expression | ISO | Cd180 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CD180 mRNA | CTD | PMID:38701888 | Cd180 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CD180 mRNA | CTD | PMID:32145629|PMID:41034487 | Cd180 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of CD180 gene | CTD | PMID:28505145 | Cd180 | Rat | buta-1,3-diene | decreases expression | ISO | Cd180 (Mus musculus) | 6480464 | 1,3-butadiene results in decreased expression of CD180 mRNA | CTD | PMID:29038090 | Cd180 | Rat | cadmium atom | multiple interactions | ISO | CD180 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CD180 more ... | CTD | PMID:35301059 | Cd180 | Rat | cadmium dichloride | multiple interactions | ISO | CD180 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CD180 more ... | CTD | PMID:35301059 | Cd180 | Rat | CGP 52608 | multiple interactions | ISO | CD180 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CD180 gene] | CTD | PMID:28238834 | Cd180 | Rat | choline | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Cd180 | Rat | cocaine | decreases expression | EXP | | 6480464 | Cocaine results in decreased expression of CD180 mRNA | CTD | PMID:27899881 | Cd180 | Rat | dextran sulfate | increases expression | ISO | Cd180 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of CD180 mRNA | CTD | PMID:23894361 | Cd180 | Rat | dextran sulfate | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD180 more ... | CTD | PMID:29950665 | Cd180 | Rat | Dibutyl phosphate | affects expression | ISO | CD180 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CD180 mRNA | CTD | PMID:37042841 | Cd180 | Rat | dimethylarsinic acid | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Cd180 | Rat | diquat | decreases expression | ISO | Cd180 (Mus musculus) | 6480464 | Diquat results in decreased expression of CD180 mRNA | CTD | PMID:36851058 | Cd180 | Rat | disodium selenite | decreases expression | ISO | Cd180 (Mus musculus) | 6480464 | Sodium Selenite results in decreased expression of CD180 mRNA | CTD | PMID:23274088 | Cd180 | Rat | doxorubicin | decreases expression | ISO | Cd180 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of CD180 mRNA | CTD | PMID:39631538 | Cd180 | Rat | epoxiconazole | affects expression | ISO | Cd180 (Mus musculus) | 6480464 | epoxiconazole affects the expression of CD180 mRNA | CTD | PMID:35436446 | Cd180 | Rat | fluorescein 5-isothiocyanate | affects binding | ISO | CD180 (Homo sapiens) | 6480464 | Fluorescein-5-isothiocyanate binds to CD180 protein | CTD | PMID:27129696 | Cd180 | Rat | folic acid | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Cd180 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CD180 mRNA | CTD | PMID:26194646 | Cd180 | Rat | L-methionine | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Cd180 | Rat | lipopolysaccharide | multiple interactions | ISO | CD180 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CD180 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Cd180 | Rat | lipopolysaccharide | decreases expression | ISO | CD180 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of CD180 mRNA | CTD | PMID:35811015 | Cd180 | Rat | methylarsonic acid | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Cd180 | Rat | nevirapine | decreases expression | ISO | Cd180 (Mus musculus) | 6480464 | Nevirapine results in decreased expression of CD180 mRNA | CTD | PMID:38636494 | Cd180 | Rat | nickel atom | decreases expression | ISO | CD180 (Homo sapiens) | 6480464 | Nickel results in decreased expression of CD180 mRNA | CTD | PMID:23195993 | Cd180 | Rat | nickel atom | increases expression | ISO | CD180 (Homo sapiens) | 6480464 | Nickel results in increased expression of CD180 mRNA | CTD | PMID:24768652|PMID:25583101 | Cd180 | Rat | nitrates | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CD180 more ... | CTD | PMID:35964746 | Cd180 | Rat | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of CD180 mRNA | CTD | PMID:31397875 | Cd180 | Rat | paracetamol | affects expression | ISO | Cd180 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CD180 mRNA | CTD | PMID:17562736 | Cd180 | Rat | progesterone | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of CD180 mRNA | CTD | PMID:19693291 | Cd180 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CD180 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CD180 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Cd180 | Rat | sodium arsenate | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Cd180 | Rat | sodium arsenite | increases expression | ISO | Cd180 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of CD180 protein | CTD | PMID:29044176 | Cd180 | Rat | sodium arsenite | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Cd180 | Rat | sodium arsenite | increases expression | ISO | CD180 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of CD180 mRNA | CTD | PMID:34032870 | Cd180 | Rat | sulforaphane | decreases expression | ISO | CD180 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of CD180 mRNA | CTD | PMID:26833863 | Cd180 | Rat | testosterone | decreases expression | ISO | Cd180 (Mus musculus) | 6480464 | Testosterone results in decreased expression of CD180 mRNA | CTD | PMID:19693291 | Cd180 | Rat | tetrachloromethane | increases expression | ISO | Cd180 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CD180 mRNA | CTD | PMID:27339419 | Cd180 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CD180 mRNA | CTD | PMID:31150632 | Cd180 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CD180 mRNA | CTD | PMID:23411599 | Cd180 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CD180 mRNA | CTD | PMID:34492290 | Cd180 | Rat | titanium dioxide | multiple interactions | ISO | Cd180 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD180 more ... | CTD | PMID:29950665 | Cd180 | Rat | triphenyl phosphate | affects expression | ISO | CD180 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of CD180 mRNA | CTD | PMID:37042841 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















